Effect of Deferiprone on Oxidative-Stress and Iron-Overload in Low Risk Transfusion-Dependent MDS Patients

NCT02477631 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

19

Enrollment

OTHER_GOV

Sponsor class

Conditions

Myelodysplastic Syndrome With Low-grade Lesions
Iron Overload Due to Repeated Red Blood Cell Transfusions

Interventions

DRUG: Deferiprone

Sponsor

Sheba Medical Center

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]